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Introduction
Paget’s disease of bone (PDB) is the second most 
common metabolic bone disease. This condition, 
characterised by abnormal bone remodelling, has a 
prevalence of 5-8% in patients of European ancestry 
over the age of 55 years.1-4 The majority of patients 
are asymptomatic. Diagnosis is based on the distinct 
radiological picture or on the elevation of serum 
alkaline phosphatase (ALP). Malignant sarcomatous 
degeneration is a rare (< 1%) and often fatal 
complication of PDB.5-8 Osteosarcoma is considered to 
be a rare and devastating complication of PDB. We 
report on a confirmed case of very rare telangiectatic 
osteosarcoma in monostotic PDB.
Case study
A 60-year-old female patient of mixed ancestry 
presented with a 6-12 month history of progressively 
worsening left hip and pelvic pain, which increased in 
severity at night and at rest. Conventional pelvic X-rays 
revealed classical features of PDB, involving the left 
iliac and pelvic bone (Figure 1 a and b). 
However, significant weight loss (> 10% body weight in 
three months), an elevated erythrocyte sedimentation 
rate of 65 mm/hour, and radiological evidence of 
progressive destruction of the left superior pubic ramus 
prompted further investigation. Biochemical analysis 
showed a moderate elevation of ALP of 227 IU/l 
(normal reference range 35-120 IU/l). However, other 
more sensitive biomarkers of bone resorption (urinary 
deoxypyridinoline and the creatinine ratio) and bone 
formation (osteocalcin) were not elevated.  
Although sarcomatous degeneration or unrelated 
metastatic disease in PDB was a distinct possibility, 
the initial biochemical and standard radiological 
evaluation was not definitive. Alternative and more 
benign conditions were also considered, including a 
giant cell tumour of bone or an aneurysmal bone cyst. 
Skeletal scintigraphy suggested that the PDB was active 
and monostotic. However an unusual photopenic area 
was localised to the left iliac bone. This phenomenon 
was described as the “doughnut sign” by Sangle and 
Layfield et al.9 It proved to be decisive in supporting 
the eventual diagnosis (Figure 2). Magnetic resonance 
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Figure 1 a (left) and b (right): Conventional pelvic X-rays show characteristic features of Paget’s disease of bone, including thickening of 
the ileopectineal line, bone expansion and coarse trabeculations. Additional findings included mixed sclerotic and lytic changes within 
the left iliac bone, accompanied by protrusio acetabuli. The arrows indicate progressive erosion and eventual destruction of the left 
superior pubic ramus. The date for Figure 1 a was December 2011. The date for Figure 1 b was March 2012.
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imaging delineated the extent of the tumour and 
showed the hallmarks of fluid-fluid levels, in keeping 
with the final histopathological diagnosis (Figures 3-4). 
The macroscopic features of a haemorrhagic tumour 
were described at the time of biopsy. Microscopic 
sections of the tissue obtained confirmed the diagnosis 
of telangiectatic osteosarcoma in PDB (Figure 5). The 
tumour consisted of osteoid-producing atypical cells 
with pleomorphic nuclei, an increase in mitotic figures 
and a moderate amount of cytoplasm. Multinucleated 
giant cells were also seen diffusely scattered throughout 
the tumour. The atypical cells lined large telangiectatic 
spaces filled with red blood cells.
Discussion
PDB is a common metabolic bone disease 
characterised by increased bone turnover, an 
imbalance in bone remodelling and distorted bone 
microarchitecture.1-4 The disease process itself involves 
various stages of lysis and sclerosis. The initial phase 
is described as osteolytic, followed by a mixed lytic 
or sclerotic phase. As the disease progresses, bone 
formation predominates, resulting in sclerotic bone 
overgrowth and deformity.5 Elevation in ALP, urinary 
deoxypyridinoline and osteocalcin typically reflects 
these increases of bone turnover. Sarcoma that arises 
in PDB is rare and presents with increasing age.6 This 
case report highlights some unique features which 
deviate from the norm and warrant clarification. 
Firstly, PDB is infrequently reported in patients who 
are not of European descent, but the geographical 
variation of PDB may be influenced by migration.2
Secondly, the moderate elevation in serum ALP is not 
congruous with the marked elevation that is typical of 
osteosarcoma or active PDB. However, osteosarcoma 
may not always be associated with very high-serum 
Figure 2: Skeletal scintigraphy. Note the central photopenic 
area in the left iliac bone (arrow). This “doughnut sign” is 
pathognomonic of telangiectatic osteosarcoma, and represents 
cystic haemorrhagic components surrounded by increased 
uptake in the septa and peripheral solid areas
Figure 3: Magnetic resonance imaging T1 post-gadolinium 
(coronal view). Large soft tissue mass in left hemipelvis 
originating from pelvic and iliac bone, and displacing adjacent 
structures
Figure 4: Magnetic resonance imaging T2 (axial view). 
Characteristic radiological feature of telangiectatic 
osteosarcoma histological variant. Mass with different-sized 
multicystic spaces within it, containing fluid-fluid levels (arrow).
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ALP.6,8 The biomarkers of bone turnover may be normal 
in PDB, suggesting a quiescent or “burnt out” phase of 
the disease, less extensive (monostotic) involvement, 
or previous exposure to bisphosphonate therapy.8 
Skeletal scintigraphy showed significant increased 
uptake in the left hemipelvis in our patient. Pagetic 
osteosarcoma is said to arise most commonly in the 
mixed lytic or sclerotic phase of the disease.5 However, 
in this case, the predominant destructive or osteolytic 
nature of the underlying tumour may have been an 
additional confounding factor, and could explain the 
apparent discrepancy between activity and limited 
changes in bone turnover markers. Telangiectatic 
osteosarcoma is described as an extremely vascular 
tumour, and increased uptake on skeletal scintigraphy 
may reflect the increased perfusion of the tumour, 
rather than increased osteoblastic activity.
Thirdly, osteosarcoma is a rare and devastating 
complication of PDB, arising in less than one per cent 
of affected individuals. Traditionally, it is thought to 
occur in patients with extensive (polyostotic) and long-
standing disease who are older than 65 years of age. 
However, as evident from current literature relating to 
osteosarcoma in PDB, this complication should not be 
discounted in the absence of long-standing disease 
and regardless of the site or stage of presentation.5-7 
Finally, various subtypes of osteosarcoma are 
described, based on the predominant cellular 
component, including osteoblastic, fibroblastic or 
chondroblastic.5,7 Telangiectatic osteosarcoma, a 
rare histological variant of osteosarcoma, is described 
in 2-12% of all osteosarcomas.5,9,10 Historically, first 
recognised by Paget in 1853 and classified as a 
distinct variant of osteosarcoma by Ewing in 1922, 
telangiectatic osteosarcoma predominantly affects 
male patients (male to female ratio of 2:1), and is seen 
more often in younger patients.10-12 When considering 
the clinical, radiological and histopathological 
features of telangiectatic osteosarcoma, it is important 
to differentiate it from an aneurysmal bone cyst and 
giant cell tumours of the bone.12,13 Distinguishing 
pathological features of this case were the destructive 
growth pattern (cortical destruction and infiltration 
of soft tissue), gross appearance (predominantly 
cystic lesion filled with blood), and the presence 
of malignant cells on microscopic examination.9-12 
Despite advances in neoadjuvant chemotherapy, the 
prognosis remains poor in the setting of all secondary 
osteosarcomas arising in PDB (a five-year survival rate 
of 10%). The poor outcome of osteosarcoma in this 
clinical setting suggests a different biological potential 
which may relate to underlying genetic susceptibility or 
environmental factors.7,14 
Clinical outcome
Surgical intervention was not considered to be a 
viable option in this patient. Palliative radiotherapy 
was initiated, but unfortunately discontinued owing to 
increased patient discomfort. Supportive management 
was limited to adequate pain relief and intravenous 
zoledronic acid. 
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Figure 5: Histopathology. Multinucleated giant cells diffusely 
scattered throughout the tumour. Atypical cells line large 
telangiectatic spaces filled with red blood cells
